| TRANSMEDICS GROUP |
| USA |
| Gesundheit |
| US89377M1099 / A2PH5P |
| 8T8 (Frankfurt) / TMDX (NASDAQ) |
| FRA:8T8, ETR:8T8, 8T8:GR, NASDAQ:TMDX |
| - |
| https://www.transmedics.c.. |
|
TransMedics Group Inc. is a commercial-stage medical technology company specializing in advanced systems and services for solid organ transplantation. Headquartered in Andover, Massachusetts, it focuses on improving the preservation, assessment, and ..
>Volltext.. |
| 2037.58 Mio. EUR |
| 2385.5 Mio. EUR |
| 557.14 Mio. EUR |
| 111.58 Mio. EUR |
| 150.63 Mio. EUR |
| 4.41 EUR |
| 756.48 Mio. EUR |
| 404.55 Mio. EUR |
| 192.95 Mio. EUR |
| 5.02 |
| 21.96% |
| 228.88% |
| - |
| - |
| - |
| TRANSMEDICS |
| 01.07.26 |
|
||||
|